Managed Access Programs for INC280, Capmatinib
Novartis
Novartis
Endevica Bio
AbbVie
Takeda
Phoenix Children's Hospital
NanOlogy, LLC
NanOlogy, LLC
Regeneron Pharmaceuticals
Nuvation Bio Inc.
Novartis
Replimune Inc.
Janssen Research & Development, LLC
Aragon Pharmaceuticals, Inc.
Novartis
ProgenaBiome
Hope Biosciences Research Foundation
Syndax Pharmaceuticals
Leap Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Janssen Research & Development, LLC
Daiichi Sankyo
Biogen
The University of Texas Health Science Center at San Antonio
Basilea Pharmaceutica